BRIEF-Avidity Biosciences Announces Positive Topline Del-Zota Data In DMD44 Trial

Reuters
17 Mar
BRIEF-Avidity Biosciences Announces Positive Topline Del-Zota Data In DMD44 Trial

March 17 (Reuters) - Avidity Biosciences Inc RNA.O:

  • AVIDITY BIOSCIENCES INC - ANNOUNCES POSITIVE TOPLINE DEL-ZOTA DATA IN DMD44 TRIAL

  • AVIDITY BIOSCIENCES INC - ON TRACK FOR YEAR-END 2025 BLA SUBMISSION FOR DEL-ZOTA IN DMD44

Source text: ID:nPn4RW9SLa

Further company coverage: RNA.O

((Reuters.Briefs@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10